Morpholinobenzamide salts

US6291458A · kind A · utility

Assignee

• ASTRAZENECA AB · SE

Inventors

• Stefan Berg · Ekerö, SE
• Daniel Sohn · Gately Drive, SE

Key dates

• Filing date: Jul 21, 2000
• Grant date: Sep 18, 2001
• Expiry date: Jul 21, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to pharmaceutically acceptable salts of the compound of formula I or solvates of said salt in which the compound of formula I is as the (R)-enantiomer, the (S)-enantiomer or the racemate, ##STR1## a process for their preparation, pharmaceutical formulations containing said therapeutically active compounds and to the use of said active compounds in therapy.